Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Comment by labon Sep 22, 2010 10:30am
261 Views
Post# 17478415

Sales By TD since Sept 1

Sales By TD since Sept 1Someone from TD has really been dumping this stock. Fortunately the buyers have cone in at .59-.60. I have been accumulating at .60.

House Positions for C:HEM from 20100901 to 20100922
House Bought $Val Ave Sold $Val Ave Net $Net
85 Scotia 616,102 371,280 0.603 70,300 43,321 0.616 545,802 -327,959
79 CIBC 307,500 185,455 0.603 15,500 9,335 0.602 292,000 -176,120
33 Canaccord 135,500 83,935 0.619 11,200 6,917 0.618 124,300 -77,018
80 National Bank 134,000 81,580 0.609 31,950 20,502 0.642 102,050 -61,078
9 BMO Nesbitt 97,639 59,292 0.607 21,098 12,498 0.592 76,541 -46,794
12 Wellington 94,500 59,505 0.63 26,000 16,490 0.634 68,500 -43,015
2 RBC 137,512 84,586 0.615 69,199 42,973 0.621 68,313 -41,613
27 Dundee 50,000 30,100 0.602 0 50,000 -30,100
19 Desjardins 41,500 25,425 0.613 7,000 4,200 0.60 34,500 -21,225
58 Qtrade 37,500 22,990 0.613 10,000 6,300 0.63 27,500 -16,690
124 Questrade 10,800 6,718 0.622 0 10,800 -6,718
89 Raymond James 23,466 14,598 0.622 17,133 10,609 0.619 6,333 -3,989
81 HSBC 5,300 3,220 0.608 1,100 693 0.63 4,200 -2,527
57 Interactive 200 124 0.62 0 200 -124
90 Barclays 100 60 0.60 0 100 -60
14 ITG 10,690 6,639 0.621 13,510 8,357 0.619 -2,820 1,718
99 Jitney 0 7,000 4,260 0.609 -7,000 4,260
62 Haywood 0 50,000 31,800 0.636 -50,000 31,800
1 Anonymous 63,000 39,125 0.621 118,000 72,935 0.618 -55,000 33,810
74 GMP 0 159,121 99,882 0.628 -159,121 99,882
7 TD Sec 303,790 187,700 0.618 1,440,988 871,260 0.605 -1,137,198 683,560
TOTAL 2,069,099 1,262,332 0.61 2,069,099 1,262,332 0.61
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse